A phase II study of spirogermanium in patients with metastatic malignant melanoma

Elizabeth A. Eisenhauer, A. Bodurtha, Kathleen I. Pritchard, Ian G. Kerr, Neill Iscoe

DOI: 10.1007/bf00179436

Investigational New Drugs

Data up to Jan 2025

Published1985

Citations9

References3

Fields

Medicine Internal medicine Oncology Gastroenterology

Total Citations Per Year

Abstract

References (3)

Spirogermanium: A new investigational drug of novel structure and lack of bone marrow toxicity

1983 • 44 citations

Spirans XXII. Synthesis of 4,4‐dialkyl‐4‐germacyclohexanone and 8,8‐dialkyl‐8‐germaazaspiro [4.5] decanes

1974 • 44 citations

Phase I clinical trial of spirogermanium.

1980 • 37 citations

Cited By (0)

Loading...